Regulation of tumor necrosis factor (TNF) gene expression was investigated in resting human monocytes and in 12-0-tetradecanoylphorbol-13-acetate (TPA) activated monocytes. TNF transcripts were undetectable in resting monocytes. However, in TPA-activated monocytes, TNF mRNA was first detectable by 3 h and reached maximal levels by 12 h of drug exposure. Using run-on transcription assays, the TNF gene was transcriptionally inactive in resting monocytes, but was rapidly activated after TPA exposure. The protein synthesis inhibitor, cycloheximide (CHX), had no detectable effect on levels of TNF transcripts in resting monocytes, while this agent superinduced the level of TNF mRNA by 50-fold in TPA-activated cells. TPA activated monocytes were also exposed to actinomycin D and/or CHX to determine whether transcriptional or posttranscriptional control of TNF gene expression was responsible for the induction of TNF transcripts. After 1 h of actinomycin D treatment, the amount of TNF transcripts was reduced by 75%. In contrast, no difference in TNF mRNA levels was observed in TPA-activated monocytes exposed to CHX alone or CHX in combination with actinomycin D. These findings indicated that CHX prevented the degradation of TNF mRNA by inhibiting the synthesis of a labile protein. Run-on transcription assays performed on cells exposed to either TPA or the combination of TPA and CHX further indicated that CHX treatment increased transcription of the TNF gene. Thus, TNF gene expression is controlled at the transcriptional level in resting human monocytes, while both transcriptional and posttranscriptional events regulate the level of TNF transcripts in TPA-activated cells.
Introduction
Monocytes can be activated in vitro to exhibit cytolytic activity against malignant cells (1) . The induction of monocyte tumoricidal activity may involve both cell contact and the secretion of distinct cytotoxic substances (1) . Tumor necrosis factor alpha (TNF-alpha)' has been described as a tumoricidal 1 . Abbreviations used in this paper: ACT, actinomycin D; CHX, cycloheximide; TNF, tumor necrosis factor; TPA, 12-O-tetradecanoylphorbol-13 acetate.
protein secreted by interleukin 1, interleukin 2, gamma-interferon or endotoxin-activated monocytes (2) (3) (4) . In contrast, circulating monocytes neither exhibit cytotoxic activity nor produce TNF, thus indicating that these functions are induced by certain stimuli (4) (5) (6) .
Treatment of human monocytes with 1 2-O-tetradecanoylphorbol-1 3 acetate (TPA) induces further differentiation of these cells along the macrophage pathway. For example, TPA phosphorylates the complement receptor CR1 on monocytes that enables these cells to mediate phagocytosis (7) . Certain protein products of activated macrophages increase after exposure of resting monocytes to TPA. These products include plasminogen activators that function as proteolytic enzymes in tissue destruction (8) and PDGF-like proteins that act as mediators of inflammation (unpublished observations). In addition, an increase in cytotoxic activity has also been found in TPA-treated monocytes (9) . Thus, TPA-treated monocytes may be useful as a model of activated macrophages.
We have studied the regulation of TNF gene expression in both resting and TPA-activated human monocytes. We report that TNF gene expression is primarily regulated at the transcriptional level in resting monocytes, while both transcriptional and posttranscriptional mechanisms regulate the level of TNF transcripts in TPA-activated monocytes.
Methods
Cell and cell culture. Peripheral blood monocytes were obtained from normal blood donors. Monocytes were isolated from plateletpheresis byproducts after Ficoll-Hypaque gradient sedimentation and adherence to plastic culture flasks for 30 min at 370C in the presence of 5% pooled human AB serum. Nonadherent cells were removed by vigorous washings with PBS. The remaining adherent cells were designated as the freshly isolated (activated) monocytes. The adherent cells were further incubated for 24-48 h in RPMI 1640 medium containing 10% fetal bovine defined serum (Hyclone Laboratories, Logan, UT). At that time, most ofthe deactivated or resting monocytes were detached from the flasks. All media were supplemented with 2 mM L-glutamine and 1% penicillin/streptomycin. TPA (33 nM), bacterial lipopolysaccharide (LPS, 1 ,ug/ml), cycloheximide (CHX; 10 ,Ag/ml) and actinomycin D (ACT; 5 ug/ml) were added to the monocyte preparations as indicated in the figure legends.
Isolation and analysis of total cellular RNA. Total cellular RNA was isolated using the guanidine thiocyanate cesium chloride method (10) and analyzed as described (1 1). Ethidium bromide staining of the agarose gels before blotting revealed the presence of equal amounts of RNA. Transcripts were visualized by autoradiography after hybridization to the following 32P-labeled probes: (a) the PE4 plasmid containing a 1.7-kb Pst I/Bam HI TNF cDNA insert (12) ; and (b) the chicken beta actin pAl plasmid (13 Transcription was terminated by the addition of40 jg/ml DNAse I, 10 mM Tris-HCG, pH 8.4, 100 mM NaCG, 1 mM EDTA and 150 U/ml RNAsin for 15 min at 260C. Proteinase K (750 jig/ml) and SDS (1%) were then added for 30 min at 37°C. Nuclear RNA was isolated by phenol/chloroform extractions and then ethanol precipitated several times in 2.5 M ammonium acetate.
Labeled nuclear RNA was hybridized to linearized DNA probes (5 ,ug) immobilized to nitrocellulose filters using a dot-blot apparatus.
Alternatively, linearized plasmids DNA (5 jg) were run in a 1% agarose gel and transferred to nitrocellulose filters by Southern blotting. Filter prehybridization was performed in 5X Denhardt's solution, 40% formamide, 4X SSC, 5 mM EDTA, 0.4% SDS and 100 jig/ml yeast tRNA for a minimum of 2 h. The labeled RNA was then heated at 80°C for 10 min in hybridization buffer (same as prehybridization buffer, except for 2X Denhardt's), chilled in ice and hybridized (minimum of 106 cpm 32P-labeled RNA/ml hybridization buffer) to the following DNAs: (a) the chicken beta actin pAl plasmid (13); (b) the JW102 plasmid carrying a human beta globin gene (14); (c) the PE4 plasmid carrying the human TNF alpha gene (12); and (d) the 6.7-kb Bam HI/Sal I fragment of the human c-src-I plasmid (15) . Measurement of TNF protein production. TNF protein concentrations in monocyte supernatants were determined by an ELISA that utilizes two different monoclonal antibodies reactive with distinct epitopes on the TNF molecule (16) . Biological activity was determined in the mouse L-929 cell cytotoxicity assay standardized with recombinant TNF. L-cells (5 X 104/well) sensitive and resistant to the cytotoxic effects of TNF were incubated in the presence of 0.1 sg/ml actinomycin D for 18 h (17). The cells were fixed and stained with 0.5% crystal violet in 20% methanol. After 10 min, the plates were washed and the dye released with 33% acetic acid. The absorbance (600 nm) of each well was determined with an automated plate reader (Bio-Rad Laboratories, Richmond, CA).
Results
Effects of TPA on TNF gene expression. TNF mRNA was undetectable by Northern analysis in resting monocytes (Fig.  1) . However, TNF transcripts were detectable by 3 h after exposure of resting monocytes to 33 nM TPA. The level of TNF mRNA reached a maximum by 12 h and then decreased to low but detectable levels. An increase in TNF mRNA was also observed after a 6-h exposure of resting monocytes to bacterial LPS (1 ,ug/ml).
Effect ofprotein synthesis inhibition on TNF gene expression. Resting and activated monocytes were exposed to CHX to determine if the level of TNF mRNA was regulated by the Exposure to actinomycin D (5 Ag/ml) for 1 h decreased the level of TNF transcripts by 75% in these cells (Fig. 2 B) . In contrast, there was no detectable decrease in TNF mRNA when cells were exposed to CHX for 5 h and then to CHX/actinomycin D for an additional 1 h.
Similar results were obtained in a more detailed time course using freshly isolated or activated monocytes that constitutively express TNF. In this study, the monocytes were exposed to CHX, actinomycin D or the combination of these agents for 1, 3, and 6 h. CHX was added 10 min before actinomycin D when cells were treated with both drugs. TNF mRNA levels decreased by > 90% after a 1-h exposure to actinomycin D, thus indicating a half-life of < 20 min (Fig. 3) . In contrast, there was no change in the level ofTNF transcripts in cells treated with both CHX and actinomycin D for 1 h. However, TNF mRNA degradation was not completely inhibited by CHX, since these transcripts were undetectable after 3 h of exposure to both drugs (Fig. 3) .
TNF gene transcription rate in resting and TPA activated monocytes. In order to analyze whether the absence of TNF transcripts in resting monocytes was secondary to transcriptional or posttranscriptional mechanisms, we measured the rate of TNF gene transcription in isolated nuclei using the run-on transcription assay procedure. As shown in Fig. 4 . TNF mRNA levels in activated monocytes exposed to ACT, CHX or the combination of these agents. Freshly isolated and activated monocytes were exposed to ACT (5 ,ug/ml), CHX (10 ug/ml) or the combination of these agents for the indicated times.
CHX was added 10 min before actinomycin D when using both agents. Total cellular RNA was hybridized to the 32P-labeled human TNF cDNA or to a 32P-labeled chicken beta actin DNA probe.
transcribed in resting monocytes, while the beta globin gene was also transcriptionally inactive. In contrast, treatment of resting monocytes was associated with a rapid increase in TNF gene transcription, which was detected as early as 20 min after drug exposure. TNF gene transcription was then compared in TPA and TPA/CHX-treated monocytes to determine whether transcriptional regulation was also responsible for the increase in TNF transcripts in activated monocytes exposed to CHX. As shown in Fig. 4 B, TNF transcription activity increased 12-fold after CHX exposure. In contrast, the rate of c-src gene transcription remained unchanged under these experimental conditions.
Effects of TPA on TNF protein production. The effects of TPA on TNF protein production were determined by both ELISA and the L-cell cytotoxicity assay. TNF protein production in supernatants of resting monocytes treated with TPA was first detectable at 3 h (Fig. 5 A) . Furthermore, the level of TNF protein increased progressively during 15 h of TPA exposure (Fig. 5 A) . Culture supernatant from monocytes treated with TPA for 12 h was monitored for biological activity against TNF sensitive and resistant L-cells (17). The TNF-sensitive L-cells were progressively killed by adding increasing amounts of culture supernatant (Fig. 5 B) . In contrast, this supernatant had loss of a cytotoxic effect against the TNF-resistant L-cells (Fig. 5 B) . Moreover, pretreatment of the supernatant with a neutralizing anti-TNF monoclonal antibody resulted in a loss of cytotoxic activity against TNF-sensitive L-cells (Fig. 5 B) . Finally, there was no detectable production of TNF protein by ELISA or L-cell cytotoxicity assay in supernatants ofuntreated resting monocytes.
Discussion
The TNF gene is transcriptionally active and TNF mRNA is detectable by Northern analysis (18, 19) (4) . Thus, the absence of TNF gene expression at the transcriptional level in resting monocytes is a major reason why these cells fail to exhibit spontaneous tumoricidal activity. In this regard, the ability of the combination of LPS and gamma interferon to induce cytotoxic activity in monocytes might be related in part to the ability of these agents to transcriptionally activate the TNF gene (18, 19 
